Epilepsy and Eschar

Summary:

Eschar is found among people with Epilepsy, especially for people who are male, 60+ old.

The study analyzes which people have Eschar with Epilepsy. It is created by eHealthMe based on reports of 15 people who have Epilepsy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,166 drugs and 1,780 conditions by eHealthMe. Check the latest studies of Epilepsy.

What is Eschar?

Eschar (dead tissue that falls off (sheds) from healthy skin) is found to be associated with 151 drugs and 337 conditions by eHealthMe. Check the latest studies of Eschar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

15 people who have Epilepsy and Eschar are studied.

Would you have Eschar when you have Epilepsy?

Gender of people who have Epilepsy and experienced Eschar *:

  • female: 20 %
  • male: 80 %

Age of people who have Epilepsy and experienced Eschar *:

  • 0-1: 0.0 %
  • 2-9: 14.29 %
  • 10-19: 14.29 %
  • 20-29: 14.29 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 21.43 %
  • 60+: 35.71 %

Common co-existing conditions for these people *:

  1. Psychotic Disorder: 4 people, 26.67%
  2. Essential Hypertension (primary hypertension): 4 people, 26.67%
  3. Pain: 1 person, 6.67%
  4. Neuralgia (pain in one or more nerves): 1 person, 6.67%
  5. Hypocholesterolaemia (presence of abnormally small amounts of cholesterol in the circulating blood): 1 person, 6.67%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
  7. Encephalopathy (functioning of the brain is affected by some agent or condition): 1 person, 6.67%

Common drugs taken by these people *:

  1. Depakene: 6 people, 40.00%
  2. Tegretol: 5 people, 33.33%
  3. Valproic Acid: 3 people, 20.00%
  4. Furosemide: 3 people, 20.00%
  5. Lamotrigine: 2 people, 13.33%
  6. Fluocinonide: 2 people, 13.33%
  7. Irbesartan: 2 people, 13.33%
  8. Keppra: 2 people, 13.33%
  9. Levetiracetam: 1 person, 6.67%
  10. Lidocaine: 1 person, 6.67%

Common symptoms for these people *:

  1. Rashes (redness): 6 people, 40.00%
  2. Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 6 people, 40.00%
  3. Confusional State: 6 people, 40.00%
  4. Weight Decreased: 4 people, 26.67%
  5. Hepatitis C: 4 people, 26.67%
  6. Mental Retardation (problems with learning and developing): 4 people, 26.67%
  7. Eyelid Ptosis (falling of the upper or lower eyelid): 4 people, 26.67%
  8. Excessive Or Unwanted Hair In Women: 4 people, 26.67%
  9. Pigmentation Disorder (disturbances of human skin colour): 4 people, 26.67%
  10. Porphyrins Urine Increased: 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Eschar?

- Check whether Eschar is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Eschar:

All the conditions that are associated with Eschar:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Eschar and Epilepsy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: